Omega Healthcare Investors Inc/ US6819361006 /
| 10/4/2024 9:59:58 PM | Chg. -0.62 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 39.35USD | -1.55% | 55,703 Turnover: 2.2 mill. |
-Bid Size: - | -Ask Size: - | 10.15 bill.USD | 6.81% | 38.96 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | - | - | - | - | - | ||||||
| Intangible Assets | - | - | - | - | - | ||||||
| Long-Term Investments | 199.9000 | 200.6000 | 194.7000 | 178.9000 | 188.4000 | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 24.1170 | 163.5350 | 20.5340 | 297.1030 | 442.8100 | ||||||
| Current Assets | - | - | - | - | - | ||||||
| Total Assets | 9,796.1240 | 9,497.4490 | 9,638.4780 | 9,405.1630 | 9,117.4020 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | - | - | - | - | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 5,459.5300 | 5,460.8420 | 5,530.2520 | 5,601.8810 | 5,355.1110 | ||||||
| Share Capital | 22.6630 | 23.1190 | 23.9060 | 23.4250 | 24.5280 | ||||||
| Total Equity | 4,336.5940 | 4,036.6070 | 4,108.2260 | 3,803.2820 | 3,762.2910 | ||||||
| Minority Interests | 201.1660 | 194.7310 | 201.3880 | 193.9140 | 187.7070 | ||||||
| Total liabilities equity | 9,796.1240 | 9,497.4490 | 9,638.4780 | 9,405.1630 | 9,117.4020 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 928.8300 | 892.3810 | 1,062.8090 | 878.2440 | 949.7400 | ||||||
| Depreciation (total) | 301.6830 | 329.9240 | 342.0140 | 332.4070 | 319.6820 | ||||||
| Operating Result | 551.7450 | - | - | - | - | ||||||
| Interest Income | - | -223.3890 | -234.6040 | -233.2440 | -235.5290 | ||||||
| Income Before Taxes | 343.8440 | 162.3270 | 416.0800 | 436.1410 | 255.6330 | ||||||
| Income Taxes | -2.8440 | -4.9250 | -3.8400 | -4.5610 | -6.2550 | ||||||
| Minority Interests Profit | -10.8240 | -4.2180 | -11.5630 | -11.9140 | -6.6160 | ||||||
| Net Income | 341.1230 | 159.3270 | 416.7390 | 426.9270 | 242.1800 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 553.7470 | 708.2560 | 722.1360 | 625.7270 | 617.7360 | ||||||
| Cash Flow from Investing Activities | -378.9530 | -89.0570 | -524.1730 | 442.8530 | -.7700 | ||||||
| Cash Flow from Financing | -153.9590 | -485.5480 | -341.1170 | -789.4470 | -473.3100 | ||||||
| Decrease / Increase in Cash | 21.7090 | 134.1780 | -143.1470 | 276.2330 | 144.0860 | ||||||
| Employees | 49 | - | - | - | - | ||||||
